WELLINGTON MANAGEMENT GROUP LLP - AMICUS THERAPEUTICS INC ownership

AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 223 filers reported holding AMICUS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.56 and the average weighting 0.3%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of AMICUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$91,488,058
-6.9%
7,523,689
-3.8%
0.02%
-5.3%
Q2 2023$98,222,918
+17.9%
7,820,296
+4.1%
0.02%
+11.8%
Q1 2023$83,341,805
-15.8%
7,515,041
-7.3%
0.02%
-15.0%
Q4 2022$98,990,706
+17.7%
8,107,347
+0.6%
0.02%
+11.1%
Q3 2022$84,109,000
-29.0%
8,056,375
-26.9%
0.02%
-25.0%
Q2 2022$118,405,000
-53.0%
11,024,744
-58.6%
0.02%
-44.2%
Q1 2022$252,083,000
-18.1%
26,619,107
-0.1%
0.04%
-12.2%
Q4 2021$307,792,000
+32.7%
26,648,674
+9.7%
0.05%
+25.6%
Q3 2021$232,024,000
+53.6%
24,295,698
+55.0%
0.04%
+56.0%
Q2 2021$151,074,000
+8.4%
15,671,449
+11.1%
0.02%0.0%
Q1 2021$139,386,000
-40.4%
14,107,972
+39.2%
0.02%
-41.9%
Q4 2020$234,052,000
+176.1%
10,136,467
+68.9%
0.04%
+138.9%
Q3 2020$84,764,000
-16.4%
6,003,155
-10.7%
0.02%
-21.7%
Q2 2020$101,387,000
+134.4%
6,723,291
+43.6%
0.02%
+109.1%
Q1 2020$43,254,000
-11.7%
4,681,177
-6.9%
0.01%
+10.0%
Q4 2019$48,977,000
-21.2%
5,028,341
-35.1%
0.01%
-28.6%
Q3 2019$62,144,000
-40.1%
7,748,814
-6.7%
0.01%
-39.1%
Q2 2019$103,693,000
-1.2%
8,308,724
+7.7%
0.02%
-4.2%
Q1 2019$104,906,000
+44.6%
7,713,651
+1.9%
0.02%
+33.3%
Q4 2018$72,540,000
-14.3%
7,571,962
+8.1%
0.02%0.0%
Q3 2018$84,648,000
-33.1%
7,001,370
-13.5%
0.02%
-35.7%
Q2 2018$126,465,000
+2.0%
8,096,364
-1.8%
0.03%0.0%
Q1 2018$123,995,000
+55.7%
8,244,333
+49.0%
0.03%
+55.6%
Q4 2017$79,621,000
-12.9%
5,533,131
-8.7%
0.02%
-14.3%
Q3 2017$91,411,000
+51.5%
6,061,734
+1.2%
0.02%
+50.0%
Q2 2017$60,327,000
+58.4%
5,990,808
+12.2%
0.01%
+55.6%
Q1 2017$38,083,000
+557.6%
5,341,132
+358.4%
0.01%
+800.0%
Q4 2016$5,791,000
-29.1%
1,165,137
+5.5%
0.00%
-50.0%
Q3 2016$8,170,000
+37.4%
1,104,117
+1.4%
0.00%0.0%
Q2 2016$5,946,000
-32.3%
1,089,017
+4.8%
0.00%0.0%
Q1 2016$8,778,000
-13.0%
1,038,773
-0.1%
0.00%
-33.3%
Q4 2015$10,084,000
-27.8%
1,039,603
+4.1%
0.00%
-25.0%
Q3 2015$13,971,000
-0.1%
998,611
+1.1%
0.00%0.0%
Q2 2015$13,983,000
+321.9%
988,200
-30.5%
0.00%
+300.0%
Q2 2013$3,314,0001,422,6960.00%
Other shareholders
AMICUS THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Palo Alto Investors LP 10,114,043$116,817,0007.46%
Parametrica Management Ltd 597,279$6,899,0006.86%
Redmile Group, LLC 22,716,086$262,371,0005.96%
Perceptive Advisors 53,118,886$613,524,0004.73%
Asymmetry Capital Management, L.P. 716,709$8,278,0004.39%
CM Management, LLC 450,000$5,198,0003.93%
Avoro Capital Advisors LLC 18,500,000$213,675,0003.64%
Kynam Capital Management, LP 573,699$6,626,0003.54%
SECTORAL ASSET MANAGEMENT INC 1,242,882$14,355,0002.16%
Ghost Tree Capital, LLC 500,000$5,775,0002.07%
View complete list of AMICUS THERAPEUTICS INC shareholders